- Home
- IMAB vs CRNC Comparison
IMAB vs CRNC Comparison
Compare IMAB & CRNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- CRNC
- Stock Information
- Founded
- IMAB 2014
- CRNC 2020
- Country
- IMAB United States
- CRNC United States
- Employees
- IMAB N/A
- CRNC N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- CRNC EDP Services
- Sector
- IMAB Health Care
- CRNC Technology
- Exchange
- IMAB Nasdaq
- CRNC Nasdaq
- Market Cap
- IMAB 394.2M
- CRNC 455.3M
- IPO Year
- IMAB 2020
- CRNC N/A
- Fundamental
- Price
- IMAB $4.39
- CRNC $12.29
- Analyst Decision
- IMAB Strong Buy
- CRNC Hold
- Analyst Count
- IMAB 6
- CRNC 5
- Target Price
- IMAB $7.17
- CRNC $10.20
- AVG Volume (30 Days)
- IMAB 1.7M
- CRNC 2.2M
- Earning Date
- IMAB 11-02-2025
- CRNC 11-20-2025
- Dividend Yield
- IMAB N/A
- CRNC N/A
- EPS Growth
- IMAB N/A
- CRNC N/A
- EPS
- IMAB N/A
- CRNC N/A
- Revenue
- IMAB N/A
- CRNC $245,947,000.00
- Revenue This Year
- IMAB N/A
- CRNC N/A
- Revenue Next Year
- IMAB N/A
- CRNC $4.85
- P/E Ratio
- IMAB N/A
- CRNC N/A
- Revenue Growth
- IMAB N/A
- CRNC N/A
- 52 Week Low
- IMAB $0.60
- CRNC $2.76
- 52 Week High
- IMAB $5.90
- CRNC $27.50
- Technical
- Relative Strength Index (RSI)
- IMAB 59.97
- CRNC 56.76
- Support Level
- IMAB $3.98
- CRNC $10.89
- Resistance Level
- IMAB $4.51
- CRNC $13.74
- Average True Range (ATR)
- IMAB 0.30
- CRNC 0.93
- MACD
- IMAB 0.07
- CRNC 0.04
- Stochastic Oscillator
- IMAB 89.30
- CRNC 50.19
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.